Cargando…
MnTE-2-PyP Suppresses Prostate Cancer Cell Growth via H(2)O(2) Production
Prostate cancer patients are often treated with radiotherapy. MnTE-2-PyP, a superoxide dismutase (SOD) mimic, is a known radioprotector of normal tissues. Our recent work demonstrated that MnTE-2-PyP also inhibits prostate cancer progression with radiotherapy; however, the mechanisms remain unclear....
Autores principales: | Zhu, Yuxiang, Kosmacek, Elizabeth A., Chatterjee, Arpita, Oberley-Deegan, Rebecca E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346125/ https://www.ncbi.nlm.nih.gov/pubmed/32512786 http://dx.doi.org/10.3390/antiox9060490 |
Ejemplares similares
-
MnTE-2-PyP protects fibroblast mitochondria from hyperglycemia and radiation exposure
por: Chatterjee, Arpita, et al.
Publicado: (2022) -
The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues
por: Shrishrimal, Shashank, et al.
Publicado: (2017) -
MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses
por: Chatterjee, Arpita, et al.
Publicado: (2020) -
The Metalloporphyrin Antioxidant, MnTE-2-PyP, Inhibits Th2 Cell Immune Responses in an Asthma Model
por: Jungsuwadee, Paiboon, et al.
Publicado: (2012) -
The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation
por: Oberley-Deegan, Rebecca E., et al.
Publicado: (2012)